Alvin S. Parven, Director at ALEXION PHARMACEUTICALS INC (ALXN), sold 30,000 shares at $92.16 ($2.7M) on 2012-11-19, disclosed to the SEC on 2012-11-21.
Open-market sale of $2.7M ALXN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $90.74 | 9,306 | $844K | 30.8% |
| 2 | $91.51 | 19,281 | $1.8M | 64.4% |
| 3 | $92.16 | 1,413 | $130K | 4.8% |
| Total | $91.30 avg | 30,000 | $2.7M | 100% |
| Filing → |
| ALXN | SELL | 2016-08-24 | $2.1M | — | Filing → |
| ALXN | SELL | 2015-11-04 | $160K | — | Filing → |
| ALXN | SELL | 2014-11-13 | $2.9M | — | Filing → |